Radiography
Volume 14, Issue 2 , Pages 144-149 , May 2008

Cancer: A cell cycle defect

  • Irene Foster

      Affiliations

    • Corresponding Author InformationTel.: +44 0117 3288920; fax: +44 0117 3288408.

Received 17 March 2006 ,Accepted 22 November 2006.

References 

  1. Bergman PJ, Harris D. Radioresistance, chemoresistance and apoptosis resistance. The past, present and future. Vet Clin North Am Small Anim Pract. 1997;27(1):47–57
  2. Story M, Kodym R. Signal transduction during apoptosis; implications for cancer therapy. Front Biosci. 1998;365–375
  3. Vermeulen K, van Bockstaele DR, Berneman ZN. The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer. Cell Prolif. 2003;36:131–149
  4. McDonnell , Meyn RE, Robertson LE. Implications of apoptotic cell death regulation in cancer therapy. Cancer Biother. 1995;6:53–60
  5. Molinari M. Cell cycle checkpoints and their activation in human cancer. Cell Prolif. 2000;33:261–274
  6. Dixon S, Soriano BJ, Lush RM, Bomer MM, Figg WD. Apoptosis: its role in the development of malignancies and its potential as a novel therapeutic target. The Ann of Pharmco. Jan 1997;31:76–81
  7. King RJB. Cancer biology. Longman; 1996;
  8. Guimarães CA, Linden R. Apoptosis and alternative deathstyles. Eur J Biochem. 2004;271:1638–1650
  9. Harms-Ringdahl M, Nicotera P, Radford JR. Radiation induced apoptosis. Mutat Res. 1996;366:171–179
  10. Vermeulen K, Berneman ZN, van Bockstaele DR. Cell cycle and apoptosis. Cell Prolif. 2003;36:165–175
  11. Bellamy COC. p53 and apoptosis. Br Med Bull. 1996;53(3):522–538
  12. Kirsch DG, Kastan MB. Tumor-suppressor p53: implications for tumor development and prognosis. J Clin Oncol. 1998;16(9):3158–3168
  13. In:  DeVita VT,  Hellman S,  Rosenberg SA editor. Cancer: principles and practice of oncolgy. 5th ed.. Philadelphia: Lippincott-Raven; 1997;
  14. Hartwell LH, Kastan MB. Cell cycle and cancer. Science. 1994;266:1821–1828
  15. Liebermann DA, Hoffman B, Steinman RA. Molecular controls of growth arrest and apoptosis: p53-dependent and independent pathways. Oncogene. 1995;11:199–210
  16. Weinberg RA. How cancer arises. Sci Am. 1996;32–40
  17. Fearson E. Human cancer syndromes: clues to the origin and nature of cancer. Science. 1997;278:1043–1050
  18. Wang X, Ohnishi T. p53-dependent signal transduction induced by stress. J Radiat Res. 1997;38:179–194
  19. Weinberg RA. Tumor supressor genes. Science. 1991;254:1138–1145
  20. Evan G, Littlewood T. A matter of life and cell death. Science. 1998;281:1317–1321
  21. Arima Y, Hirota T, Bronner C, Mousli M, Fujiwara T, Niwa S, et al. Down regulation of nuclear protein ICBP90 by p53/p21Cip1/WAF1 – dependent DNA damage checkpoint signals contributes to cell cycle arrest at G1/S transition. Genes Cells. 2004;9:131–142
  22. Dang T, Bao S, Wang X. Human Rad9 is required for the activation of S-phase checkpoint and the maintenance of chromosomal stability. Genes Cells. 2005;10:287–295
  23. Latham K, Baker GL, Musunuru K, Chen YL, Eastman SW, Wong A, et al. Cell cycle control and differentiation: mechanisms of proliferative dysfunction in cancer cells. Cancer Detect Prev. 1996;20(5):
  24. Kam PC, Ferch NI. Apoptosis: mechanisms and clinical implications. Anaesthesia. 2000;55:1081–1093
  25. Taya Y. Rb kinases and Rb-binding proteins: new points of view. TIBS. 1997;
  26. Decuadin D, Geley S, Hirsch T, Castedo M, Marchetti P, Macho A, et al. Bcl-2 and Bcl-xL antagonize the mitochondrial dysfunction preceding nuclear apoptosis induced by chemotherapeutic agents. Cancer Res. 1997;52:62–67
  27. Green DR. A Myc-induced apoptosis pathway surfaces. Science. 1997;278:1246–1247
  28. Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, et al. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science. 1997;75:1129–1136
  29. Sattler M, Liang H, Nettesheim D, Meadows RP, Harlan JE, Eberstadt M, et al. Structure of Bcl-xL-Bak peptide complex: recognition between regulators of apoptosis. Science. 1997;275:983–986
  30. Hattori H, Kuroda M, Ishida T, Shinmura K, Nagal S, Mukal K, et al. Human DNA damage checkpoints and their relevance to soft tissue sarcoma. Pathol Int. 2004;54:26–31
  31. Marumoto T, Hirota T, Morisaki T, Kunitoku N, Zhang D, Ichikawa Y, et al. Roles of aurora-A kinase in mitotic entry and G2 checkpoint in mammalian cells. Genes Cells. 2002;7:1173–1182
  32. Golias C, Charalabopoulos A, Charalabopoulos K. Cell proliferation and cell cycle control: a mini review. Int J Clin Pract. 2004;58:1134–1141
  33. Deng C, Scott F. Role of the tumor suppressor gene BRAC1 in genetic stability and mammary gland tumor formation. Oncogene. 2000;19:1059–1064
  34. Blegen H, Einhorn N, Sjövall K, Roschke A, Ghadimi B, McShane L, et al. Prognostic significance of cell cycle proteins and genomic instability in borderline, early and advanced stage ovarian carcinomas. Int J Gynecol Cancer. 2000;10:477–487

PII: S1078-8174(06)00127-1

doi: 10.1016/j.radi.2006.12.001

Radiography
Volume 14, Issue 2 , Pages 144-149 , May 2008

Article Tools

* Image Usage & Resolution